Anti-PDCD1 antibodies only have the ‘Immunostimulant’ effect by activating Teff cells, whereas anti-CD274 mAbs with a functional Fc mediated ADCC directly against tumor cells improve tumor killing without unwanted toxicities (93). Here, CD274 is linked to neoplasm.